Plenary Talk: Open Science and Research Integrity

por de la Cruz Bernabe, Rosemarie
Publicado 2023

Regulatory oversight on the use of experimental therapies during a pandemic: The case of early access to convalescent plasma therapy in three LMICs

por Bernabe, Rosemarie, Torres, Cristina, Wangge, Grace, Jimenez, Edlyn, Karbwang, Juntra
Publicado 2022

The fiduciary obligation of the physician-researcher in phase IV trials

por Bernabe, Rosemarie DLC, van Thiel, Ghislaine JMW, Raaijmakers, Jan AM, van Delden, Johannes JM
Publicado 2014

What do international ethics guidelines say in terms of the scope of medical research ethics?

por Bernabe, Rosemarie D. L. C., van Thiel, Ghislaine J. M. W., van Delden, Johannes J. M.
Publicado 2016

The risk-benefit task of research ethics committees: An evaluation of current approaches and the need to incorporate decision studies methods

por Bernabe, Rosemarie D L C, van Thiel, Ghislaine J M W, Raaijmakers, Jan A M, van Delden, Johannes J M
Publicado 2012

Ethics and the marketing authorization of pharmaceuticals: what happens to ethical issues discovered post-trial and pre-marketing authorization?

por Bernabe, Rosemarie D. L. C., van Thiel, Ghislaine J. M. W., Breekveldt, Nancy S., Gispen, Christine C., van Delden, Johannes J. M.
Publicado 2020

Phase IV non-inferiority trials and additional claims of benefit

por Bernabe, Rosemarie DLC, Wangge, Grace, Knol, Mirjam J, Klungel, Olaf H, van Delden, Johannes JM, de Boer, Anthonius, Hoes, Arno W, Raaijmakers, Jan AM, van Thiel, Ghislaine JMW
Publicado 2013